12
Participants
Start Date
December 13, 2019
Primary Completion Date
November 18, 2022
Study Completion Date
August 14, 2024
Copanlisib Hydrochloride
Given IV
Nivolumab
Given IV
Wake Forest University Health Sciences, Winston-Salem
University of Alabama at Birmingham Cancer Center, Birmingham
University of Kentucky/Markey Cancer Center, Lexington
University of Iowa/Holden Comprehensive Cancer Center, Iowa City
Mayo Clinic in Rochester, Rochester
University Health Truman Medical Center, Kansas City
The University of Kansas Cancer Center - Olathe, Olathe
University of Kansas Cancer Center, Kansas City
University of Kansas Hospital-Westwood Cancer Center, Westwood
University of Kansas Health System Saint Francis Campus, Topeka
Ascension Via Christi - Pittsburg, Pittsburg
Salina Regional Health Center, Salina
HaysMed, Hays
Huntsman Cancer Institute/University of Utah, Salt Lake City
Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
National Cancer Institute (NCI)
NIH